Exabis Library:

Welcome to the e-CCO Library!

Search by:

All Congress AbstractsCongress PresentationsScientific ArticlesToolsWebcasts

Year: Category: Sub Type:

Page: (Previous) 1 2 3 4 5 6 7 8 9 10 (Next)

The long-term safety outside clinical trials

Year: 2017

Source: ECCO'17 Barcelona

Authors: van Assche G.

Last Modified: Wednesday, 15 March 2017, 2:50 PM by ECCO Administrator

Post operative complications, IBD in the elderly, IBD and malignancy

Files: 1

The patient with psychological comorbidities: How to wean off opiates in these patients? Is there any preference in drugs?

Year: 2017

Source: ECCO'17 Barcelona

Authors: Andrews J.

Last Modified: Wednesday, 15 March 2017, 2:18 PM by ECCO Administrator

Psychologist, Psychologic comorbidity, Anxiety, Depression, Coping

Files: 1

The use of IBD medicine in patients with cancer: Which treatment should be stopped when cancer is diagnosed? Which treatment to use in a patient with a prior diagnosis with cancer?

Year: 2017

Source: ECCO'17 Barcelona

Authors: Beaugerie L.

Last Modified: Wednesday, 15 March 2017, 2:05 PM by ECCO Administrator

5-ASA, Anti-TNF agents, Thiopurines ( AZA / MP )

Files: 1

Thiopurines

Year: 2017

Source: 15th IBD Intensive Advanced Course

Authors: Irving P.

Last Modified: Wednesday, 15 March 2017, 1:16 PM by Vesna Babaja

Pharmacogenetics,Pharmacokinetics, Thiopurines (AZA/MP)

Files: 1

Tips, tricks and pitfalls for peer reviewers

Source: Webcast - ECCO 2016 Amsterdam Congress - 9th Y-ECCO Career Workshop : Session 2: Group session - Reviewing a scientific paper (Keywords: ECCO)

Authors: Laurence Egan

Last Modified: Monday, 3 July 2017, 1:30 PM by Carmen Sera

Treat to target in paediatric IBD – same as in adults?

Year: 2017

Source: 4th P-ECCO Educational Course

Authors: van Rheenen P.

Last Modified: Wednesday, 15 March 2017, 1:35 PM by ECCO Administrator

Calprotectin, Colonoscopy, CRP, Disease activity indices, Patient reported outcomes, Paediatric, Treat to target

Files: 1

Treating the pregnant woman with IBD: Should anti-TNF be stopped during pregnancy? Should vedolizumab be stopped during pregnancy?

Year: 2017

Source: ECCO'17 Barcelona

Authors: van der Woude J.

Last Modified: Wednesday, 15 March 2017, 2:01 PM by ECCO Administrator

Fertility, IBD and breastfeeding, IBD in pregnancy

Files: 1

Trial endpoint vs. therapeutic objectives

Year: 2017

Source: ECCO'17 Barcelona

Authors: Baert F.

Last Modified: Wednesday, 15 March 2017, 4:55 PM by Vesna Babaja

Outcome measures, Patient reported outcomes, Histological remission, Disease activity indices, Mucosal healing

Files: 1

Under what circumstances can Faecal Calprotectin replace colonoscopy

Year: 2016

Source: ECCO Talking Heads

Authors: Edouard Louis, Patrick van Rheenen, Iris Dotan

Created: Friday, 17 March 2017, 9:50 AM by Vesna Babaja

Understanding Cancer Risk in IBD Patients

Year: 2016

Source: ECCO Talking Heads

Authors: Tine Jess, Ebbe Langholz

Created: Friday, 17 March 2017, 9:28 AM by Vesna Babaja

Ustekinumab

Year: 2017

Source: 15th IBD Intensive Advanced Course

Authors: Ferrante M.

Last Modified: Wednesday, 15 March 2017, 1:25 PM by Vesna Babaja

Crohn's disease, Disease activity Indices, Ustekinumab, Colonoscopy

Files: 1

Vedolizumab

Year: 2017

Source: 15th IBD Intensive Advanced Course

Authors: Lindsay J.

Last Modified: Wednesday, 15 March 2017, 1:24 PM by Vesna Babaja

Therapeutic drug monitoring, Vedolizumab

Files: 1

Vedolizumab in children and other biologics after TNF – what can we extrapolate? A case-based discussion

Year: 2017

Source: 4th P-ECCO Educational Course

Authors: Escher H.

Last Modified: Monday, 27 March 2017, 9:26 AM by Vesna Babaja

Ustekinumab, Vedolizumab, Paediatric

Files: 1

Web-based registries

Year: 2018

Source: ECCO'18 Vienna

Authors: Juillerat Pascal